Clinical activity and safety of sintilimab, bevacizumab, and TMZ in patients with recurrent glioblastoma. - Lu, Yinghao; Liao, Limin; Du, Kunpeng; Mo, Jianhua; Zou, Xia; Liang, Junxian; Chen, Jiahui; Tang, Wenwen; Su, Liwei; Wu, Jieping; Zhang, Junde; Tan, Yujing (BMC Cancer, 2024)